Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma

Shinichi Tsutsui, Hiroshi Inoue, Kazuhiro Yasuda, Kosuke Suzuki, Kouichirou Tahara, Hidefumi Higashi, Shoichi Era, Masaki Mori

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

BACKGROUND. It was previously demonstrated that PTEN protein expression is reduced in 67 of 236 (28%) breast carcinomas. Recent experimental studies suggested that the cell cycle inhibitor p27Kip1 (p27) is a downstream mediator through which PTEN negatively regulates cell cycle progression. METHODS. The immunohistochemic expression of p27 and PTEN protein expression was evaluated in a series of 228 invasive ductal carcinomas of the breast. RESULTS. PTEN protein expression was found to have decreased in 65 of 228 (29%) cases, while the nuclear accumulation of p27 protein was low in 99 of 228 (43%) cases. A reduced PTEN protein expression correlated significantly (P = 0.0214) with a low p27 protein expression. Univariate analysis indicated that the patients demonstrating a combined decrease in PTEN and p27 protein expression have a significantly (P = 0.0044) worse disease-free survival (DFS) than those with other combinations of these two protein expression patterns, while multivariate analysis indicated that the lymph node status, MIB-1 counts, and the combination of PTEN/p27 protein expression (P = 0.0452) are independently significant prognostic factors for DFS. CONCLUSIONS. A reduced PTEN protein expression correlated significantly with a low p27 protein expression in breast carcinoma. The finding that the patients with a combined decrease in both protein expressions had a poor prognosis thus suggests that a combined loss of PTEN and p27 function is associated with an aggressive phenotype in breast carcinoma.

Original languageEnglish
Pages (from-to)2048-2053
Number of pages6
JournalCancer
Volume104
Issue number10
DOIs
Publication statusPublished - Nov 15 2005

Fingerprint

PTEN Phosphohydrolase
Cyclin-Dependent Kinase Inhibitor p27
Breast Neoplasms
Disease-Free Survival
Cell Cycle
Carcinoma, Ductal, Breast
Proteins
Multivariate Analysis
Lymph Nodes
Phenotype

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Tsutsui, S., Inoue, H., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., ... Mori, M. (2005). Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma. Cancer, 104(10), 2048-2053. https://doi.org/10.1002/cncr.21471

Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma. / Tsutsui, Shinichi; Inoue, Hiroshi; Yasuda, Kazuhiro; Suzuki, Kosuke; Tahara, Kouichirou; Higashi, Hidefumi; Era, Shoichi; Mori, Masaki.

In: Cancer, Vol. 104, No. 10, 15.11.2005, p. 2048-2053.

Research output: Contribution to journalArticle

Tsutsui, S, Inoue, H, Yasuda, K, Suzuki, K, Tahara, K, Higashi, H, Era, S & Mori, M 2005, 'Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma', Cancer, vol. 104, no. 10, pp. 2048-2053. https://doi.org/10.1002/cncr.21471
Tsutsui S, Inoue H, Yasuda K, Suzuki K, Tahara K, Higashi H et al. Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma. Cancer. 2005 Nov 15;104(10):2048-2053. https://doi.org/10.1002/cncr.21471
Tsutsui, Shinichi ; Inoue, Hiroshi ; Yasuda, Kazuhiro ; Suzuki, Kosuke ; Tahara, Kouichirou ; Higashi, Hidefumi ; Era, Shoichi ; Mori, Masaki. / Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma. In: Cancer. 2005 ; Vol. 104, No. 10. pp. 2048-2053.
@article{c107466116fc48b8bd298fb96da8d000,
title = "Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma",
abstract = "BACKGROUND. It was previously demonstrated that PTEN protein expression is reduced in 67 of 236 (28{\%}) breast carcinomas. Recent experimental studies suggested that the cell cycle inhibitor p27Kip1 (p27) is a downstream mediator through which PTEN negatively regulates cell cycle progression. METHODS. The immunohistochemic expression of p27 and PTEN protein expression was evaluated in a series of 228 invasive ductal carcinomas of the breast. RESULTS. PTEN protein expression was found to have decreased in 65 of 228 (29{\%}) cases, while the nuclear accumulation of p27 protein was low in 99 of 228 (43{\%}) cases. A reduced PTEN protein expression correlated significantly (P = 0.0214) with a low p27 protein expression. Univariate analysis indicated that the patients demonstrating a combined decrease in PTEN and p27 protein expression have a significantly (P = 0.0044) worse disease-free survival (DFS) than those with other combinations of these two protein expression patterns, while multivariate analysis indicated that the lymph node status, MIB-1 counts, and the combination of PTEN/p27 protein expression (P = 0.0452) are independently significant prognostic factors for DFS. CONCLUSIONS. A reduced PTEN protein expression correlated significantly with a low p27 protein expression in breast carcinoma. The finding that the patients with a combined decrease in both protein expressions had a poor prognosis thus suggests that a combined loss of PTEN and p27 function is associated with an aggressive phenotype in breast carcinoma.",
author = "Shinichi Tsutsui and Hiroshi Inoue and Kazuhiro Yasuda and Kosuke Suzuki and Kouichirou Tahara and Hidefumi Higashi and Shoichi Era and Masaki Mori",
year = "2005",
month = "11",
day = "15",
doi = "10.1002/cncr.21471",
language = "English",
volume = "104",
pages = "2048--2053",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma

AU - Tsutsui, Shinichi

AU - Inoue, Hiroshi

AU - Yasuda, Kazuhiro

AU - Suzuki, Kosuke

AU - Tahara, Kouichirou

AU - Higashi, Hidefumi

AU - Era, Shoichi

AU - Mori, Masaki

PY - 2005/11/15

Y1 - 2005/11/15

N2 - BACKGROUND. It was previously demonstrated that PTEN protein expression is reduced in 67 of 236 (28%) breast carcinomas. Recent experimental studies suggested that the cell cycle inhibitor p27Kip1 (p27) is a downstream mediator through which PTEN negatively regulates cell cycle progression. METHODS. The immunohistochemic expression of p27 and PTEN protein expression was evaluated in a series of 228 invasive ductal carcinomas of the breast. RESULTS. PTEN protein expression was found to have decreased in 65 of 228 (29%) cases, while the nuclear accumulation of p27 protein was low in 99 of 228 (43%) cases. A reduced PTEN protein expression correlated significantly (P = 0.0214) with a low p27 protein expression. Univariate analysis indicated that the patients demonstrating a combined decrease in PTEN and p27 protein expression have a significantly (P = 0.0044) worse disease-free survival (DFS) than those with other combinations of these two protein expression patterns, while multivariate analysis indicated that the lymph node status, MIB-1 counts, and the combination of PTEN/p27 protein expression (P = 0.0452) are independently significant prognostic factors for DFS. CONCLUSIONS. A reduced PTEN protein expression correlated significantly with a low p27 protein expression in breast carcinoma. The finding that the patients with a combined decrease in both protein expressions had a poor prognosis thus suggests that a combined loss of PTEN and p27 function is associated with an aggressive phenotype in breast carcinoma.

AB - BACKGROUND. It was previously demonstrated that PTEN protein expression is reduced in 67 of 236 (28%) breast carcinomas. Recent experimental studies suggested that the cell cycle inhibitor p27Kip1 (p27) is a downstream mediator through which PTEN negatively regulates cell cycle progression. METHODS. The immunohistochemic expression of p27 and PTEN protein expression was evaluated in a series of 228 invasive ductal carcinomas of the breast. RESULTS. PTEN protein expression was found to have decreased in 65 of 228 (29%) cases, while the nuclear accumulation of p27 protein was low in 99 of 228 (43%) cases. A reduced PTEN protein expression correlated significantly (P = 0.0214) with a low p27 protein expression. Univariate analysis indicated that the patients demonstrating a combined decrease in PTEN and p27 protein expression have a significantly (P = 0.0044) worse disease-free survival (DFS) than those with other combinations of these two protein expression patterns, while multivariate analysis indicated that the lymph node status, MIB-1 counts, and the combination of PTEN/p27 protein expression (P = 0.0452) are independently significant prognostic factors for DFS. CONCLUSIONS. A reduced PTEN protein expression correlated significantly with a low p27 protein expression in breast carcinoma. The finding that the patients with a combined decrease in both protein expressions had a poor prognosis thus suggests that a combined loss of PTEN and p27 function is associated with an aggressive phenotype in breast carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=27644505704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644505704&partnerID=8YFLogxK

U2 - 10.1002/cncr.21471

DO - 10.1002/cncr.21471

M3 - Article

VL - 104

SP - 2048

EP - 2053

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 10

ER -